Table 1 Demographic data and pre- and postoperative neurological, neuropsychiatric, and cognitive measures

n

5

5

Age

59.0 (± 9.9)

*

Gender (male/female)

1/4

*

Disease duration (years)

8.4 (± 1.8)

*

MDS-UPDRS part III

25.8 (± 13.9) (med-ON)

14.0 (± 6.7) (med-ON, stim-ON)

LEDD (mg/day)

1432.0 (± 624.6)

545.0 (± 253.5)

DA daily dose (mg/day)

212.0 (± 184.2)

80.0 (± 63.2)

SAS

8.8 (± 3.7)

9.6 (± 4.7)

HADS-A

9.0 (± 2.0)

3.4 (± 2.2)

HADS-D

7.0 (± 2.0)

2.2 (± 1.9)

QUIP-RS present

13.8 (± 12.8)

6.4 (± 9.7)

MoCA

27.6 (± 2.3)

27.2 (± 1.3)